CD300C reduces lung adenocarcinoma susceptibility through regulation of CD62L⁻ monocytes: a Mendelian randomization study.
Saved in:
| Title: | CD300C reduces lung adenocarcinoma susceptibility through regulation of CD62L⁻ monocytes: a Mendelian randomization study. |
|---|---|
| Authors: | Chen H; College of Marine Sciences, Ningde Normal University, Ningde, China., Xue Z; Department of Respiratory and Critical Care Medicine, Ningde Municipal Hospital of Ningde Normal University, Ningde, Fujian, China., Huang L; Clinical laboratory, Ningde Clinical Medical College of Fujian Medical University, Ningde, China., Zeng Y; Department of painology, Ningde Clinical Medical College of Fujian Medical University, Ningde, China., Tang M; Department of Respiratory and Critical Care Medicine, Ningde Municipal Hospital of Ningde Normal University, Ningde, Fujian, China., Han K; Engineering Research Center of Mindong Aquatic Product Deep-Processing, Ningde, China., Chen J; Ningde Yiye Marine Industry Development Co., Ltd, Ningde, China., Deng X; Department of Respiratory and Critical Care Medicine, Ningde Municipal Hospital of Ningde Normal University, Ningde, Fujian, China., Fang G; Department of Respiratory and Critical Care Medicine, Ningde Municipal Hospital of Ningde Normal University, Ningde, Fujian, China. fangguiju2@163.com. |
| Source: | Discover oncology [Discov Oncol] 2026 Jan 24; Vol. 17 (1), pp. 326. Date of Electronic Publication: 2026 Jan 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2730-6011 |
|---|---|
| DOI: | 10.1007/s12672-026-04481-8 |
